ReviewInfection and drug resistance2023

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus.

Benjamín Diethelm-Varela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.